After reconstituting NAD+ (nicotinamide adenine dinucleotide), how long does the vial remain usable under refrigerated (2‑8 °C) and room temperature conditions?

Reconstituted NAD+ Stability

Once reconstituted, NAD+ vials should be stored at 2-8°C (refrigerated) and used according to manufacturer specifications, though specific post-reconstitution stability data is extremely limited in the available evidence. 1

Storage Recommendations

The FDA drug label information indicates that NAD+ products should be stored at 2-8°C 1, but critically, none of the provided evidence specifies exact post-reconstitution stability timeframes for NAD+ formulations used clinically.

Key Stability Considerations

Inherent NAD+ Instability Issues

NAD+ and its reduced form (NADH) are highly susceptible to degradation, particularly through:

• Oxidation reactions - NADH readily oxidizes to NAD+ during sample handling and storage 2
• Temperature sensitivity - Redox-active species like NADH show substantial degradation even under controlled conditions 2
• Time-dependent interconversion - Metabolite extracts containing NAD species can degrade or interconvert over time 2

Research demonstrates that NADH stability is surprisingly better in anhydrous organic solvents compared to aqueous solutions 3, but this applies to research storage conditions, not clinical reconstituted vials.

Clinical Practice Guidance

What You Should Do:

1. Follow manufacturer-specific instructions on the product insert for your exact NAD+ formulation
2. Refrigerate immediately after reconstitution at 2-8°C 1
3. Use as soon as possible after reconstitution - the evidence strongly suggests that NAD species are unstable in aqueous solution 2
4. Minimize time between preparation and administration to prevent degradation 2

Common Pitfalls to Avoid:

• Do not assume room temperature stability - while some refrigerated medications tolerate room temperature excursions 4, 5, no specific data supports this for reconstituted NAD+
• Do not store long-term after reconstitution - the biochemical evidence indicates ongoing degradation in aqueous solutions 2
• Avoid repeated freeze-thaw cycles if any portion is saved

Evidence Limitations

The available evidence has significant gaps: the FDA label provides storage temperature 1 but no post-reconstitution timeframe, and the biochemical literature 2 demonstrates NAD+ instability but doesn't provide clinical vial stability data. In the absence of specific manufacturer guidance, err on the side of caution and use reconstituted NAD+ within 24 hours when refrigerated, or ideally the same day of reconstitution.